NCT06229067 2024-01-29Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Not yet recruiting182 enrolled